Cevec Pharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 18, 2015
Pages: 38
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CB719B28593EN
Leaflet:

Download PDF Leaflet

Cevec Pharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

CEVEC Pharmaceuticals GmbH (CEVEC) is a biopharmaceutical company that develops and manufactures complex therapeutic proteins, monoclonal antibodies and vaccines with human glycosylation patterns. The company uses its platform expression technologies, CAP and CAP-T, that developed on the basis of immortalized suspension cells extracted from primary human amniocytes, to manufacture biopharmaceutical molecules and vaccines. It co-developed its first CAP cell derived molecule with Alloksys Life Science BV (Netherlands), which is in clinical Phase I trial. CEVEC also operates customer projects and supports contract research organizations, contract manufacturing organizations, and pharmaceutical and biotechnology companies. The company out-licenses its expression technology platform and product candidates through partnerships with biotechnology and pharmaceutical companies. CEVEC is headquartered in Koln, Germany.

Cevec Pharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Cevec Pharma Raises US$3.6 Million In Extended Series C Financing
CEVEC Pharma Raises US$8.6 Million In Series C Financing
CEVEC Pharma Secures US$5.4 Million In Series B Financing
CEVEC Pharma Raises US$5.9 Million In Venture Financing
Partnerships
Catalent Pharma Enters Into Co-Development Agreement With Cevec Pharma
CEVEC Pharma Enters Into Technology Integration Agreement With Catalent Pharma
CEVEC Enters Into An Agreement With Alloksys Life Sciences And PharmaCell
Licensing Agreements
Vibalogics Enters into Licensing Agreement with Cevec Pharma for CAP Technology
Cevec Pharma Enters Into Licensing Agreement With Vakzine Projekt Management For CMV Dense Body Technology
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins
Cevec Pharma Enters Into Licensing Agreement With CCS Cell Culture Service
CEVEC Pharma Announces Licensing Agreement With Paragon Bioservices For Proprietary Human Cell Lines
CEVEC Pharma Enters Into Licensing Agreement With Life Technologies
CEVEC Pharma Enters Into License Option Agreement With Pevion Biotech
Aragen Bioscience Enters Into Licensing Agreement With CEVEC Pharma
Inno Biologics Enteres Into Licensing Agreement With CEVEC Pharma
InVivo BioTech Signs Licensing Agreement With CEVEC Pharma
Cevec Pharmaceuticals GmbH - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Key Facts
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Deals By Therapy Area, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Cevec Pharma Raises US$3.6 Million In Extended Series C Financing
CEVEC Pharma Raises US$8.6 Million In Series C Financing
CEVEC Pharma Secures US$5.4 Million In Series B Financing
CEVEC Pharma Raises US$5.9 Million In Venture Financing
Catalent Pharma Enters Into Co-Development Agreement With Cevec Pharma
CEVEC Pharma Enters Into Technology Integration Agreement With Catalent Pharma
CEVEC Enters Into An Agreement With Alloksys Life Sciences And PharmaCell
Vibalogics Enters into Licensing Agreement with Cevec Pharma for CAP Technology
Cevec Pharma Enters Into Licensing Agreement With Vakzine Projekt Management For CMV Dense Body Technology
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins
Cevec Pharma Enters Into Licensing Agreement With CCS Cell Culture Service
CEVEC Pharma Announces Licensing Agreement With Paragon Bioservices For Proprietary Human Cell Lines
CEVEC Pharma Enters Into Licensing Agreement With Life Technologies
CEVEC Pharma Enters Into License Option Agreement With Pevion Biotech
Aragen Bioscience Enters Into Licensing Agreement With CEVEC Pharma
Inno Biologics Enteres Into Licensing Agreement With CEVEC Pharma
InVivo BioTech Signs Licensing Agreement With CEVEC Pharma
Cevec Pharmaceuticals GmbH, Key Competitors
Cevec Pharmaceuticals GmbH, Key Employees
Cevec Pharmaceuticals GmbH, Subsidiaries

LIST OF FIGURES
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Cevec Pharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: